544 related articles for article (PubMed ID: 9486993)
1. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
2. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
Savage S; Johnson Nagel N; Estacio RO; Feig PU; MacCarthy EP; Lukken NJ; Ziegler R; Schrier RW
Online J Curr Clin Trials; 1993 Nov; Doc No 104():[6250 words; 128 paragraphs]. PubMed ID: 8305994
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
Estacio RO; Schrier RW
Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
[TBL] [Abstract][Full Text] [Related]
5. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel blockers for hypertension--uncertainty continues.
Cutler JA
N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
[No Abstract] [Full Text] [Related]
7. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
[TBL] [Abstract][Full Text] [Related]
9. Nisoldipine and myocardial infarction.
Osende JI
N Engl J Med; 1998 Jul; 339(2):126; author reply 127. PubMed ID: 9669898
[No Abstract] [Full Text] [Related]
10. Nisoldipine and myocardial infarction.
Walker AM
N Engl J Med; 1998 Jul; 339(2):126; author reply 127. PubMed ID: 9669899
[No Abstract] [Full Text] [Related]
11. Nisoldipine and myocardial infarction.
Molitch ME
N Engl J Med; 1998 Jul; 339(2):126-7; author reply 127. PubMed ID: 9669900
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
13. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
14. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial.
Schrier RW; Estacio RO; Jeffers B
Diabetologia; 1996 Dec; 39(12):1646-54. PubMed ID: 8960857
[TBL] [Abstract][Full Text] [Related]
15. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
16. The calcium channel antagonist debate: recent developments.
Lubsen J
Eur Heart J; 1998 Aug; 19 Suppl I():I3-7. PubMed ID: 9743437
[TBL] [Abstract][Full Text] [Related]
17. Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.
Schrier RW; Estacio RO
N Engl J Med; 2000 Dec; 343(26):1969. PubMed ID: 11186674
[No Abstract] [Full Text] [Related]
18. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
20. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M; Lang R; Rachmani R; Lishner M
Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
